HTGF News

Stay up to date

Our press pages provide up-to-date information on important developments at the High-Tech Gründerfonds and in the HTGF family. This also includes news from our portfolio companies.

We are convinced that a strong start-up ecosystem is important for Germany as a business centre. As one of the leading seed investors in Europe, with around 1.4 billion euros under management, we are an important part of this ecosystem. We want to strengthen it, which also involves providing information about our work. We are the media’s go-to contact for all matters relating to start-ups, venture capital and, of course, our portfolio companies. Please get in touch with us.

Press
Team GlassDollar
31. May 2023

GlassDollar connects leading corporations to cutting-edge startups to build the world of tomorrow

GlassDollar raises €2M (led by HTGF) to match startup solutions to corporate challenges and design the world of tomorrow. Through data, software and operational support, GlassDollar provides a Venture Clienting OS that helps corporate innovators use startup solutions to achieve tangible impact — on their organization and the world. Customers include leading innovation units at Bosch Siemens home-appliances, Volkswagen, A2A, LG, MTU and Infineon. In March, GlassDollar closed a
 
Press
30. May 2023

A European champion for fusion: Proxima Fusion spins out of the Max Planck Institute for Plasma Physics

Munich, May 30th 2023 - Proxima Fusion, a fusion start-up that is designing fusion power plants based on the stellarator concept, completed its pre-seed fundraising of €7m. The fundraising is co-led by Plural and UVC Partners, and joined by High-Tech Gründerfonds (HTGF) and the Wilbe Group. Proxima Fusion is the first spin-out from the Max Planck Institute for Plasma Physics (IPP). The startup was founded by former scientists and engineers from the Max Planck IPP, MIT, and Google-X. Th
 
Press
23. May 2023

smartbax Announces Seed Financing of €1.2 Million to Develop Next-generation Antibiotics

Munich, Germany, May 23, 2023 – smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the close of its seed financing round of €1.2 million from Boehringer Ingelheim Venture Fund (BIVF) and High-Tech Gründerfonds (HTGF), bringing smartbax’s total capital raised to €1.9 million. The funds will be used to advance smartbax’s small molecule antibiotics through preclinical studies, expand the company’s scientific tea
 
Press
15. May 2023

Using an app to combat skin conditions: Nia Health receives millions in funding

The Berlin-based health tech start-up Nia Health receives 3.5 million euros in a seed financing round. The company originates from the Charité Universitätsmedizin Berlin and operates leading dermatology apps, including "Nia," the most widely downloaded app for people with atopic dermatitis. The company has a network of renowned cooperation partners consisting of pharmaceutical companies, health insurance companies and clinics. The great potential lies above all in Nia Health's ex
 
Press
Dualyx Logo
15. May 2023

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic

Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeting TNFR2, as well as its pipeline of Treg candidates Financing co-led by Fountain Healthcare Partners, Forbion and Andera Partners with support from existing investors Bernard Coulie appointed as Independent Chairman with immediate effect May 15, 2023, Ghent, Belgium – Dualyx NV, a Ghent based biotech developing next generation immune modulators, today announces that it has
 
Press
MDs HTGF
11. May 2023

HTGF Family Day 2023 brings together start-ups, companies and investors

The HTGF Family Day 2023 attracted over 1,000 participants from all over Europe to Bonn, including founders, investors and innovators. Speakers included Christian Lindner, Simone Menne, Anna Christmann, Kenza Ait Si Abbou and Christian Angermayer. The winners of the Venture Clienting Awards 2023, which GlassDollar presented in cooperation with HTGF, were DB Schenker, Bosch, BSH Startup Kitchen and Siemens Energy. In 2024, the important networking event for the start-up and investor
 
Press
Romy Schnelle HTGF
8. May 2023

High-Tech Gründerfonds expands management team: Partner Romy Schnelle made Managing Director 

Bonn, 8th May 2023 – The Investor Advisory Board has appointed Romy Schnelle (44) as a Managing Director of High-Tech Gründerfonds (HTGF). Together with Dr. Alex von Frankenberg and Guido Schlitzer, she is responsible for managing one of Europe’s leading seed investors. HTGF launched its fourth fund in February and now manages around €1.4 billion of capital in total. With around €500 million in this fund, HTGF can invest even more capital in each start-up.  Romy Schnelle h
 
Press
Maschinenraum Logo
26. April 2023

Bringing medium-sized businesses into the future together: Maschinenraum cooperates with Germany's leading venture capitalists

Maschinenraum, the ecosystem transforming German-speaking family businesses, is allying with Germany's leading venture capitalists (VCs). The strategic partnerships allow the now nearly 70 family-owned companies to directly engage with renowned venture capitalists and start-ups to better prepare for the future. For the cross-industry network of family businesses, the partnerships are another opportunity to jointly solve the most pressing questions and tasks of forward-looking transformations
 
Press
DearEmployee Team
24. April 2023

DearEmployee secures fresh capital in pre-Series A to further expand and strengthen market position

Potsdam, Germany - April 24, 2023 - DearEmployee, the innovation leader in HR tech, announces the closing of a pre-Series A round. In particular, the fresh capital from new and existing investors will be used to further expand the functionality of the software solution along customer needs and to build the processes and structures for further growth, including the future location in Potsdam. Mental illnesses are the most common reason for loss of working capacity and contribute significan